Filing Flows › Xtant Medical Holdings (XTNT) › Q4 2024
Xtant Medical Holdings (XTNT) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 6, 2025
Xtant Medical Holdings (XTNT) reported revenue of $31.5M for the fourth quarter 2024 (Q4 2024), +12% from a year earlier and +13% from the quarter before. Operating margin was -6.0%, net loss $3.2M (10.0% of revenue).
Xtant Medical Holdings, Q4 2024: revenue $31.5M (+12% year over year), operating margin -6.0%, net loss $3.2M, operating cash flow $665K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.5M | +13% | +12% |
| Operating profit | −$1.9M | — | — |
| Net earnings | −$3.2M | — | — |
| Operating cash flow | $665K | — | — |
What changed
Revenue was $31.5M in Q4 2024, up 12% year over year and up 13% from the previous quarter.
Gross margin was 50.8%, down 10.1 points from a year earlier. Operating costs exceeded revenue by $1.9M, an operating margin of -6.0%. Operating expenses fell 15% while revenue rose 12%. The quarter ended with a net loss of $3.2M, narrower than the previous quarter's $5.0M loss.
Operating cash flow was $665K. Non-cash charges added back $1.1M of depreciation and amortization and $840K of share-based compensation. Working capital and other items added $1.8M. Capital expenditures of $672K exceeded it, leaving free cash flow of −$7K.
Questions
What was Xtant Medical Holdings' revenue in the fourth quarter 2024?
Xtant Medical Holdings (XTNT) reported revenue of $31.5M for the fourth quarter 2024 (Q4 2024), +12% from a year earlier and +13% from the quarter before.
Was Xtant Medical Holdings profitable in the fourth quarter 2024?
Operating loss was $1.9M (-6.0% of revenue) and net loss $3.2M.